Aberrant acetylation of histones surrounding proto-oncogenes during oncogenesis and tumor progression suggests that BET proteins may play a role in cancer cell proliferation, survival, and oncogenic progression, providing a rationale for using BET inhibitors as anticancer drugs5–7,10–17. The gene discussed is DNER; the disease is cancer.